Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Hideki Fujii, Norifumi Kawada
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3863-3863
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutiérrez–Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 148
Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
Mona A. Eldosoky, Reham Hammad, Asmaa A. Elmadbouly, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3157-3157
Open Access | Times Cited: 55
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 28
A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD
Wenyuan Dong, Yu-Xin Gong, Jianqi Zhao, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 21
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 19
NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials
Tushar Khare, Karina Liu, Lindiwe Oslee Chilambe, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 306-306
Open Access | Times Cited: 4
Submicron Dispersions of Phytosterols Reverse Liver Steatosis with Higher Efficacy than Phytosterol Esters in a Diet Induced-Fatty Liver Murine Model
Raimundo Gillet, Tomás G. Cerda-Drago, María C. Brañes, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 564-564
Open Access | Times Cited: 2
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials
Takumi Kawaguchi, Michael Charlton, Atsushi Kawaguchi, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 03, pp. 225-234
Closed Access | Times Cited: 68
Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
Ji‐Xian Song, Ji‐Ren An, Qi Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 8334-8348
Open Access | Times Cited: 67
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 48
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
В. Т. Ивашкин, M. V. Maevskaya, М. С. Жаркова, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2022) Vol. 32, Iss. 4, pp. 104-140
Open Access | Times Cited: 46
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
Marija Branković, Igor Jovanović, Marija Dukić, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5146-5146
Open Access | Times Cited: 41
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 31
The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
Qin Ling, Jiawei Chen, Xiao Liu, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 27
Collagens Regulating Adipose Tissue Formation and Functions
Iida Jääskeläinen, Tiina Petäistö, Elahe Mirzarazi Dahagi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1412-1412
Open Access | Times Cited: 25
The cGAS-STING pathway: a therapeutic target in diabetes and its complications
Wenjie He, Xingrui Mu, Xingqian Wu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 14
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota
Wenkai Zhang, Longhui Yu, Qinru Yang, et al.
Phytomedicine (2024) Vol. 127, pp. 155478-155478
Closed Access | Times Cited: 13
Anti-inflammatory benefits of semaglutide: State of the art
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100340-100340
Open Access | Times Cited: 13
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 11
Oligonucleotide therapies for nonalcoholic steatohepatitis
Sixu Li, Feng Xiong, Songbo Zhang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102184-102184
Open Access | Times Cited: 9
Silibinin as a major component of milk thistle seed provides promising influences against diabetes and its complications: a systematic review
Parisa Zare Mehrjerdi, Sara Asadi, Elham Ehsani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7531-7549
Closed Access | Times Cited: 9
Pediococcus acidilactici CECT 9879 (pA1c®) and heat inactivated pA1c® (pA1c® HI) ameliorate gestational diabetes mellitus in mice
Deyan Yavorov-Dayliev, Fermı́n I. Milagro, Josune Ayo, et al.
Life Sciences (2025) Vol. 362, pp. 123359-123359
Closed Access | Times Cited: 1
The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis
Yunyi Yang, Xiaoli He, Shufa Tan, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus
Rikita Hatia, Lu-Yu Hwang, Ruosha Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 93-106
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top